.png)
What’s Hot
- As expected, China is dominant over the month, with some funds up in excess of 20%.
- 7 of the top funds are Chinese.
- 2 funds are Asian, reminding us that Asia as a whole is also a beneficiary of a more stable China.
- Similarly with emerging markets generally, China being the biggest component.
What’s Not
- 5 of the duds are UK smaller company funds.
- Notably, 4 are micro/AIM funds, where the greatest concerns might lie ahead of the Budget.
- 2 biotech/healthcare funds suggest disappointment with the pipeline of new drugs.
What’s Hot
|
Name
|
Sector
|
Last Month’s
Performance %
|
|
FSSA All China
|
China/Greater China
|
27.07
|
|
Baillie Gifford China
|
China/Greater China
|
21.38
|
|
M&G China
|
China/Greater China
|
20.78
|
|
Invesco China Equity (UK)
|
China/Greater China
|
19.24
|
|
Allianz China A-Shares Equity
|
China/Greater China
|
17.77
|
|
Janus Henderson China Opportunities
|
China/Greater China
|
17.30
|
|
FSSA Greater China Growth
|
China/Greater China
|
13.35
|
|
Ninety One Asia Pacific Franchise
|
Asia Pacific Excluding Japan
|
10.23
|
|
TM Redwheel Global Emerging Markets Fund
|
Global Emerging Markets
|
8.66
|
|
Fidelity Sustainable Asia Equity
|
Asia Pacific Excluding Japan
|
8.52
|
What’s Not
|
Name
|
Sector
|
Last Month’s
Performance %
|
|
Liontrust Russia
|
Specialist
|
-8.57
|
|
WS Guinness Global Energy
|
Commodity/Natural Resources
|
-8.03
|
|
FP Octopus UK Micro Cap Growth
|
UK Smaller Companies
|
-7.82
|
|
Liontrust UK Micro Cap
|
UK Smaller Companies
|
-7.75
|
|
MI Canaccord Genuity UK Smaller Companies
|
UK Smaller Companies
|
-7.47
|
|
AXA Framlington Biotech
|
Specialist
|
-6.99
|
|
IFSL Marlborough UK Micro-Cap Growth
|
UK Smaller Companies
|
-6.68
|
|
Thesis Stonehage Fleming AIM TR
|
UK Smaller Companies
|
-6.60
|
|
Slater Recovery
|
UK All Companies
|
-5.82
|
|
Schroder Global Healthcare
|
Global
|
-5.64
|
Fund performance 01/09/2024 – 30/09/2024. Funds <50m in size and ETFs excluded from the above research.
NOTE
We do this blog to simply highlight short term trends. These are not recommendations.